Structural basis for the broad, antibody-mediated neutralization of H5N1 influenza virus

Journal of Virology

Volumn 92, Issue 17, 2018, Pages

  Lin, Qingshan ^a   Li, Tingting ^a   Chen, Yixin ^a   Lau, Siu Ying ^b   Wei, Minxi ^a   Zhang, Yuyun ^a   Zhang, Zhenyong ^a   Yao, Qiaobin ^a   Li, Jinjin ^a   Li, Zhihai ^a   Wang, Daning ^a   Zheng, Qingbing ^a   Yu, Hai ^a   Gu, Ying ^a   Zhang, Jun ^a   Chen, Honglin ^a,b   Li, Shaowei ^a   Xia, Ningshao ^a  

^a XIAMEN UNIVERSITY   (China)

^b THE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Antibody; Avian influenza virus; Broad specific neutralization; Receptor binding site

Indexed keywords

ARGININE; ASPARAGINE; INFLUENZA VIRUS HEMAGGLUTININ; LEUCINE; LYSINE; NEUTRALIZING ANTIBODY; NEUTRALIZING ANTIBODY 13D4; TRYPTOPHAN; UNCLASSIFIED DRUG; HEMAGGLUTININ, AVIAN INFLUENZA A VIRUS; MUTANT PROTEIN; PROTEIN BINDING; VIRUS ANTIBODY;

ANTIGENICITY; ARTICLE; BINDING SITE; COMPLEMENTARITY DETERMINING REGION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; GENE MUTATION; GENETIC POLYMORPHISM; IMMUNE EVASION; INFLUENZA A VIRUS (H5N1); NONHUMAN; PRIORITY JOURNAL; VIRUS NEUTRALIZATION; AMINO ACID SUBSTITUTION; ANIMAL; CHEMISTRY; DNA MUTATIONAL ANALYSIS; GENETICS; IMMUNOLOGY; MOLECULAR MODEL; MOUSE; PROTEIN CONFORMATION; X RAY CRYSTALLOGRAPHY;

AMINO ACID SUBSTITUTION; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CRYSTALLOGRAPHY, X-RAY; DNA MUTATIONAL ANALYSIS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; IMMUNE EVASION; INFLUENZA A VIRUS, H5N1 SUBTYPE; MICE; MODELS, MOLECULAR; MUTANT PROTEINS; PROTEIN BINDING; PROTEIN CONFORMATION;

EID: 85051829041     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00547-18     Document Type: Article

References (67)

1. Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y. 2006. Avian flu: influenza virus receptors in the human airway. Nature 440:435-436. https://doi.org/10.1038/440435a
2. Yamada S, Suzuki Y, Suzuki T, Le MQ, Nidom CA, Sakai-Tagawa Y, Muramoto Y, Ito M, Kiso M, Horimoto T, Shinya K, Sawada T, Kiso M, Usui T, Murata T, Lin Y, Hay A, Haire LF, Stevens DJ, Russell RJ, Gamblin SJ, Skehel JJ, Kawaoka Y. 2006. Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to humantype receptors. Nature 444:378-382. https://doi.org/10.1038/ nature05264
3. de Vries E, Guo H, Dai M, Rottier PJ, van Kuppeveld FJ, de Haan CA. 2015. Rapid emergence of highly pathogenic avian influenza subtypes from a subtype H5N1 hemagglutinin variant. Emerg Infect Dis 21:842-846. https://doi.org/10.3201/eid2105.141927
4. Park AW, Glass K. 2007. Dynamic patterns of avian and human influenza in east and southeast Asia. Lancet Infect Dis 7:543-548. https://doi.org/ 10.1016/S1473-3099(07)70186-X
5. Xu X, Subbarao Cox NJ, Guo Y. 1999. Genetic characterization of the pathogenic influenza A/Goose/Guangdong/1/96 (H5N1) virus: similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong. Virology 261:15-19. https://doi.org/10.1006/ viro.1999.9820
6. Wan X-F, Dong L, Lan Y, Long L-P, Xu C, Zou S, Li Z, Wen L, Cai Z, Wang W, Li X, Yuan F, Sui H, Zhang Y, Dong J, Sun S, Gao Y, Wang M, Bai T, Yang L, Li D, Yang W, Yu H, Wang S, Feng Z, Wang Y, Guo Y, Webby RJ, Shu Y. 2011. Indications that live poultry markets are a major source of human H5N1 influenza virus infection in China. J Virol 85:13432-13438. https://doi.org/10.1128/JVI.05266-11
7. Verhagen JH, Herfst S, Fouchier RA. 2015. Infectious disease. How a virus travels the world. Science 347:616-617. https://doi.org/10.1126/science.aaa6724
8. Bi Y, Chen Q, Wang Q, Chen J, Jin T, Wong G, Quan C, Liu J, Wu J, Yin R, Zhao L, Li M, Ding Z, Zou R, Xu W, Li H, Wang H, Tian K, Fu G, Huang Y, Shestopalov A, Li S, Xu B, Yu H, Luo T, Lu L, Xu X, Luo Y, Liu Y, Shi W, Liu D, Gao GF. 2016. Genesis, evolution and prevalence of H5N6 avian influenza viruses in China. Cell Host Microbe 20:810-821. https://doi.org/10.1016/j.chom.2016.10.022
9. Yang L, Zhu W, Li X, Bo H, Zhang Y, Zou S, Gao R, Dong J, Zhao X, Chen W, Dong L, Zou X, Xing Y, Wang D, Shu Y. 2017. Genesis and dissemination of highly pathogenic H5N6 avian influenza viruses. J Virol 91: e02199-16. https://doi.org/10.1128/JVI.02199-16
10. van der Vries E, Martin S, Pieter F, Charles B, Albert O. 2013. Influenza virus resistance to antiviral therapy. Adv Pharmacol 67:217-246. https:// doi.org/10.1016/B978-0-12-405880-4.00006-8
11. Kilbourne ED. 2006. Influenza pandemics of the 20th century. Emerg Infect Dis 12:9-14. https://doi.org/10.3201/eid1201.051254
12. Webster RG, Govorkova EA. 2006. H5N1 influenza: continuing evolution and spread. N Engl J Med 355:2174-2177. https://doi.org/10.1056/NEJMp068205
13. Stöhr K. 2005. Avian influenza and pandemics: research needs and opportunities. N Engl J Med 352:405-407. https://doi.org/10.1056/ NEJMe048344
14. Ungchusak K, Auewarakul P, Dowell SF, Kitphati R, Auwanit W, Puthavathana P, Uiprasertkul M, Boonnak K, Pittayawonganon C, Cox NJ, Zaki SR, Thawatsupha P, Chittaganpitch M, Khontong R, Simmerman JM, Chunsutthiwat S. 2005. Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med 352:333-340. https://doi.org/10.1056/ NEJMoa044021
15. Krammer F, Palese P, Steel J. 2015. Advances in universal influenza virus vaccine design and antibody mediated therapies based on conserved regions of the hemagglutinin. Curr Top Microbiol Immunol 386:301-321. https://doi.org/10.1007/82_2014_408
16. Tan Y, He F, Kwang J. 2015. How can we develop universal H5N1 vaccines. Immunotherapy 7:713-716. https://doi.org/10.2217/imt.15.42
17. Prabakaran M, Kolpe AB, He F, Kwang J. 2013. Cross-protective efficacy of bivalent recombinant baculoviral vaccine against heterologous influenza H5N1 challenge. Vaccine 31:1385-1392. https://doi.org/10.1016/j.vaccine.2013.01.003
18. Skehel JJ, Wiley DC. 2000. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 69:531-569. https://doi.org/10.1146/annurev.biochem.69.1.531
19. Weis W, Brown JH, Cusack S, Paulson JC, Skehel JJ, Wiley DC. 1988. Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid. Nature 333:426-431. https://doi.org/10.1038/ 333426a0
20. Barbey-Martin C, Gigant B, Bizebard T, Calder LJ, Wharton SA, Skehel JJ, Knossow M. 2002. An antibody that prevents the hemagglutinin low pH fusogenic transition. Virology 294:70-74. https://doi.org/10.1006/viro.2001.1320
21. Chen Y, Qin K, Wu WL, Li G, Zhang J, Du H, Ng MH, Shih JW, Peiris JS, Guan Y, Chen H, Xia N. 2009. Broad cross-protection against H5N1 avian influenza virus infection by means of monoclonal antibodies that map to conserved viral epitopes. J Infect Dis 199:49-58. https://doi.org/10.1086/ 594374
22. Zuo T, Sun J, Wang G, Jiang L, Zuo Y, Li D, Shi X, Liu X, Fan S, Ren H, Hu H, Sun L, Zhou B, Liang M, Zhou P, Wang X, Zhang L. 2015. Comprehensive analysis of antibody recognition in convalescent humans from highly pathogenic avian influenza H5N1 infection. Nat Commun 6:8855. https://doi.org/10.1038/ncomms9855
23. Sui J, Hwang WC, Perez S, Wei G, Aird D, Chen L-M, Santelli E, Stec B, Cadwell G, Ali M, Wan H, Murakami A, Yammanuru A, Han T, Cox NJ, Bankston LA, Donis RO, Liddington RC, Marasco WA. 2009. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol 16:265-273. https://doi.org/10.1038/nsmb.1566
24. Lee PS, Wilson IA. 2015. Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies. Curr Top Microbiol Immunol 386:323-341. https://doi.org/10.1007/82_2014_413
25. Velkov T, Ong C, Baker MA, Kim H, Li J, Nation RL, Huang JX, Cooper MA, Rockman S. 2013. The antigenic architecture of the hemagglutinin of influenza H5N1 viruses. Mol Immunol 56:705-719. https://doi.org/10.1016/j.molimm.2013.07.010
26. Air GM. 2015. Influenza virus antigenicity and broadly neutralizing epitopes. Curr Opin Virol 11:113-121. https://doi.org/10.1016/j.coviro.2015.03.006
27. Corti D, Lanzavecchia A. 2013. Broadly neutralizing antiviral antibodies. Annu Rev Immunol 31:705-742. https://doi.org/10.1146/annurev-immunol-032712-095916
28. Tonegawa S. 1983. Somatic generation of antibody diversity. Nature 302:575-581. https://doi.org/10.1038/302575a0
29. Finn JA, Crowe JE, Jr. 2013. Impact of new sequencing technologies on studies of the human B cell repertoire. Curr Opin Immunol 25:613-618. https://doi.org/10.1016/j.coi.2013.09.010
30. Finn JA, Koehler Leman J, Willis JR, Cisneros A, Crowe JE, Meiler J. 2016. Improving loop modeling of the antibody complementaritydetermining region 3 using knowledge-based restraints. PLoS One 11:e0154811. https://doi.org/10.1371/journal.pone.0154811
31. Wu NC, Wilson IA. 2017. A perspective on the structural and functional constraints for immune evasion: insights from influenza virus. J Mol Biol 429:2694-2709. https://doi.org/10.1016/j.jmb.2017.06.015
32. Corti D, Cameroni E, Guarino B, Kallewaard NL, Zhu Q, Lanzavecchia A. 2017. Tackling influenza with broadly neutralizing antibodies. Curr Opin Virol 24:60-69. https://doi.org/10.1016/j.coviro.2017.03.002
33. Whittle JRR, Zhang R, Khurana S, King LR, Manischewitz J, Golding H, Dormitzer PR, Haynes BF, Walter EB, Moody MA, Kepler TB, Liao H-X, Harrison SC. 2011. Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin. Proc Natl Acad Sci U S A 108:14216-14221. https://doi.org/10.1073/ pnas.1111497108
34. Schmidt AG, Xu H, Khan AR, O'Donnell T, Khurana S, King LR, Manischewitz J, Golding H, Suphaphiphat P, Carfi A, Settembre EC, Dormitzer PR, Kepler TB, Zhang R, Moody MA, Haynes BF, Liao H-X, Shaw DE, Harrison SC. 2013. Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody. Proc Natl Acad Sci U S A 110:264-269. https://doi.org/10.1073/pnas.1218256109
35. Sun L, Lu X, Li C, Wang M, Liu Q, Li Z, Hu X, Li J, Liu F, Li Q, Belser JA, Hancock K, Shu Y, Katz JM, Liang M, Li D. 2009. Generation, characterization and epitope mapping of two neutralizing and protective human recombinant antibodies against influenza A H5N1 viruses. PLoS One 4:e5476. https://doi.org/10.1371/journal.pone.0005476
36. Stevens J, Corper AL, Basler CF, Taubenberger JK, Palese P, Wilson IA. 2004. Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus. Science 303:1866-1870. https://doi.org/10.1126/science.1093373
37. Krissinel HE. 2007. Inference of macromolecular assemblies from crystalline state. J Mol Biol 372:774-797. https://doi.org/10.1016/j.jmb.2007.05.022
38. Winarski KL, Thornburg NJ, Yu Y, Sapparapu G, Crowe JE, Spiller BW. 2015. Vaccine-elicited antibody that neutralizes H5N1 influenza and variants binds the receptor site and polymorphic sites. Proc Natl Acad Sci U S A 112:9346-9351. https://doi.org/10.1073/pnas.1502762112
39. Crusat M, Liu J, Palma AS, Childs RA, Liu Y, Wharton SA, Lin YP, Coombs PJ, Martin SR, Matrosovich M, Chen Z, Stevens DJ, Hien VM, Thanh TT, Nhu LN, Te NT, Nguyet LA, Ha DQ, van Doorn HR, Hien TT, Conradt HS, Kiso M, Gamblin SJ, Chai W, Skehel JJ, Hay AJ, Farrar J, de Jong MD, Feizi T. 2013. Changes in the hemagglutinin of H5N1 viruses during human infection-influence on receptor binding. Virology 447:326-337. https:// doi.org/10.1016/j.virol.2013.08.010
40. Hong M, Lee PS, Hoffman RM, Zhu X, Krause JC, Laursen NS, Yoon S-I, Song L, Tussey L, Crowe JE, Ward AB, Wilson IA. 2013. Antibody recognition of the pandemic H1N1 influenza virus hemagglutinin receptor binding site. J Virol 87:12471-12480. https://doi.org/10.1128/JVI.01388-13
41. Fleury D, Wharton SA, Skehel JJ, Knossow M, Bizebard T. 1998. Antigen distortion allows influenza virus to escape neutralization. Nat Struct Biol 5:119. https://doi.org/10.1038/nsb0298-119
42. Xu R, Krause JC, McBride R, Paulson JCJE, Jr, Wilson IA. 2013. A recurring motif for antibody recognition of the receptor-binding site of influenza hemagglutinin. Nat Struct Mol Biol 20:363-370. https://doi.org/10.1038/ nsmb.2500
43. Xiong X, Corti D, Liu J, Pinna D, Foglierini M, Calder LJ, Martin SR, Lin YP, Walker PA, Collins PJ, Monne I, Suguitan AL, Santos C, Temperton NJ, Subbarao K, Lanzavecchia A, Gamblin SJ, Skehel JJ. 2015. Structures of complexes formed by H5 influenza hemagglutinin with a potent broadly neutralizing human monoclonal antibody. Proc Natl Acad Sci U S A 112:9430-9435. https://doi.org/10.1073/pnas.1510816112
44. Zhu X, Guo Y-H, Jiang T, Wang Y-D, Chan K-H, Li X-F, Yu W, McBride R, Paulson JC, Yuen K-Y, Qin C-F, Che X-Y, Wilson IA. 2013. A unique and conserved neutralization epitope in H5N1 influenza viruses identified by an antibody against the A/Goose/Guangdong/1/96 hemagglutinin. J Virol 87:12619-12635. https://doi.org/10.1128/JVI.01577-13
45. Brandenburg B, Koudstaal W, Goudsmit J, Klaren V, Tang C, Bujny MV, Korse HJ, Kwaks T, Otterstrom JJ, Juraszek J, van Oijen AM, Vogels R, Friesen RH. 2013. Mechanisms of hemagglutinin targeted influenza virus neutralization. PLoS One 8:e80034. https://doi.org/10.1371/journal.pone.0080034
46. Strauch E-MM, Bernard SM, La D, Bohn AJ, Lee PS, Anderson CE, Nieusma T, Holstein CA, Garcia NK, Hooper KA, Ravichandran R, Nelson JW, Sheffler W, Bloom JD, Lee KK, Ward AB, Yager P, Fuller DH, Wilson IA, Baker D. 2017. Computational design of trimeric influenza-neutralizing proteins targeting the hemagglutinin receptor binding site. Nat Biotechnol 35:667-671. https://doi.org/10.1038/nbt.3907
47. Hu T, Song J, Zhang W, Zhao H, Duan B, Liu Q, Zeng W, Qiu W, Chen G, Zhang Y, Fan Q, Zhang F. 2015. Emergence of novel clade 2.3.4 influenza A (H5N1) virus subgroups in Yunnan Province, China. Infect Genet Evol 33:95-100. https://doi.org/10.1016/j.meegid.2015.04.016
48. Okamatsu M, Ozawa M, Soda K, Takakuwa H, Haga A, Hiono T, Matsuu A, Uchida Y, Iwata R, Matsuno K, Kuwahara M, Yabuta T, Usui T, Ito H, Onuma M, Sakoda Y, Saito T, Otsuki K, Ito T, Kida H. 2017. Characterization of highly pathogenic avian influenza virus A(H5N6), Japan, November 2016. Emerg Infect Dis 23:691-695. https://doi.org/10.3201/eid2304.161957
49. Jiang H, Wu P, Uyeki TM, He J, Deng Z, Xu W, Lv Q, Zhang J, Wu Y, Tsang TK, Kang M, Zheng J, Wang L, Yang B, Qin Y, Feng L, Fang VJ, Gao GF, Leung GM, Yu H, Cowling BJ. 2017. Preliminary epidemiologic assessment of human infections with highly pathogenic avian influenza A(H5N6) virus, China. Clin Infect Dis 65:383-388. https://doi.org/10.1093/ cid/cix334
50. Ren H, Wang G, Wang S, Chen H, Chen Z, Hu H, Cheng G, Zhou P. 2016. Cross-protection of newly emerging HPAI H5 viruses by neutralizing human monoclonal antibodies: a viable alternative to oseltamivir. MAbs 8:1156-1166. https://doi.org/10.1080/19420862.2016.1183083
51. Gerhard W, Yewdell J, Frankel ME, Webster R. 1981. Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies. Nature 290:713-717. https://doi.org/10.1038/290713a0
52. Caton AJ, Brownlee GG, Yewdell JW, Gerhard W. 1982. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31:417-427. https://doi.org/10.1016/0092-8674(82)90135-0
53. Skehel JJ, Stevens DJ, Daniels RS, Douglas AR, Knossow M, Wilson IA, Wiley DC. 1984. A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody. Proc Natl Acad Sci U S A 81:1779-1783. https://doi.org/10.1073/pnas.81.6.1779
54. Wiley DC, Wilson IA, Skehel JJ. 1981. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289:373-378. https://doi.org/10.1038/289373a0
55. Gu Y, Tang X, Zhang X, Song C, Zheng M, Wang K, Zhang J, Ng M-H, Hew C-L, Li S, Xia N, Sivaraman J. 2015. Structural basis for the neutralization of hepatitis E virus by a cross-genotype antibody. Cell Res 25:604-620. https://doi.org/10.1038/cr.2015.34
56. Rupp B. 2010. Biomolecular crystallography: principles, practice, and application to structural biology. Garland Science, New York, NY
57. Chen VB, Arendall WB, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, Murray LW, Richardson JS, Richardson DC. 2010. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr 66:12-21. https://doi.org/10.1107/ S0907444909042073
58. Ekiert DC, Kashyap AK, Steel J, Rubrum A, Bhabha G, Khayat R, Lee JH, Dillon MA, O'Neil RE, Faynboym AM, Horowitz M, Horowitz L, Ward AB, Palese P, Webby R, Lerner RA, Bhatt RR, Wilson IA. 2012. Crossneutralization of influenza A viruses mediated by a single antibody loop. Nature 489:526-532. https://doi.org/10.1038/nature11414
59. Lee PS, Yoshida R, Ekiert DC, Sakai N, Suzuki Y, Takada A, Wilson IA. 2012. Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity. Proc Natl Acad Sci U S A 109:17040-17045. https://doi.org/10.1073/pnas.1212371109
60. Lee PS, Ohshima N, Stanfield RL, Yu W, Iba Y, Okuno Y, Kurosawa Y, Wilson IA. 2014. Receptor mimicry by antibody F045-092 facilitates universal binding to the H3 subtype of influenza virus. Nat Commun 5:3614. https://doi.org/10.1038/ncomms4614
61. Abhinandan KR, Martin ACR. 2008. Analysis and improvements to Kabat and structurally correct numbering of antibody. Mol Immunol. 45: 3832-3839. https://doi.org/10.1016/j.molimm.2008.05.022
62. Zhang Z, Li R, Jiang L, Xiong C, Chen Y, Zhao G, Jiang Q. 2016. The complexity of human infected AIV H5N6 isolated from China. BMC Infect Dis 16:600. https://doi.org/10.1186/s12879-016-1932-1
63. Tsibane T, Ekiert DC, Krause JC, Martinez O, Crowe JE, Wilson IA, Basler CF. 2012. Influenza human monoclonal antibody 1F1 interacts with three major antigenic sites and residues mediating human receptor specificity in H1N1 viruses. PLoS Pathog 8:e1003067. https:// doi.org/10.1371/journal.ppat.1003067
64. Wu WL, Chen Y, Wang P, Song W, Lau S-Y, Rayner JM, Smith GJ, Webster RG, Peiris JS, Lin T, Xia N, Guan Y, Chen H. 2008. Antigenic profile of avian H5N1 viruses in Asia from 2002 to 2007. J Virol 82:1798-1807. https:// doi.org/10.1128/JVI.02256-07
65. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn Storoni LC, Read RJ. 2007. Phaser crystallographic software. J Appl Crystallogr 40:658-674. https://doi.org/10.1107/S0021889807021206
66. Emsley P, Cowtan K. 2004. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60:2126-2132. https://doi.org/10.1107/S0907444904019158
67. Adams PD, Afonine PV, Bunkóczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung L-W, Kapral GJ, Grosse-Kunstleve RW, McCoy AJ, Moriarty NW, Oeffner R, Read RJ, Richardson DC, Richardson JS, Terwilliger TC, Zwart PH. 2010. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66:213-221. https://doi.org/10.1107/S0907444909052925